【摘要】 目的　观察复治重症肺结核采用胸腺肽辅助治疗的疗效。方法　胸腺肽 2 0 mg静滴 ,每日 1次。结果　加用胸腺肽治疗组痰菌阴转率 6个月末为 5 7.6 %、9个月末为 6 9.5 %、12个月末为 89.8% ;吸收好转率 6个月末为 5 2 .5 %、8个月末为 5 7.6 %、10个月末为 6 7.8% ;满疗程结束后痊愈率为 79.7%。两年随访 ,加用胸腺肽治疗组有 1例痰菌转阳 (2 .3% ) ,对照组有 4例痰菌转阳 (12 .9% )。结论　加用胸腺肽辅助治疗可提高复治重症肺结核的临床疗效更多还原

【Abstract】 Objective To observe the curative effect of thymus peptide as a supplementary cure in the retreatment of serious pulmonary tuberculosis.Methods Intravenous drip of thymus peptide was given 20 mg qd.Results The negative turning rate of phlegm bacteria in the group of thymus peptide were 57.6%(at the end of 6 months),69.5%(at the end of 9 months),and 89.8%(at the end of 12 months)raspectively;The rate of absorption were recorded as 52.5%(at the end of 6 months),57.6%(at the end of 8 months)and 67.8%(at the end of 10 months).The rate of recovery after the whole course of treatment reached 79.7%.The follow up of 2 years revealed one positive turning of phlegm hacteria in the group of thymus peptide(2.3%),while in the control group 4 cases(12.9%)turning positive.Conclusion The application of thymus peptide as a supplementary cure may improve the curative effect in the retreatment of serious pulmonary tuberculosis.更多还原